Colorado Springs, CO6 Active Studies

Leukemia Clinical Trials in Colorado Springs, CO

Find 6 actively recruiting leukemia clinical trials in Colorado Springs, CO. Connect with local research sites and explore new treatment options.

6
Active Trials
5
Sponsors
3,046
Enrolling

Recruiting Leukemia Studies in Colorado Springs

About Leukemia Clinical Trials in Colorado Springs

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 6 leukemia clinical trials recruiting participants in Colorado Springs, CO. These studies are seeking a combined 3,046 participants. Research is being sponsored by SWOG Cancer Research Network, Merck Sharp & Dohme LLC, Eli Lilly and Company and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Colorado Springs — FAQ

Are there leukemia clinical trials in Colorado Springs?

Yes, there are 6 leukemia clinical trials currently recruiting in Colorado Springs, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Colorado Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Colorado Springs research site will contact you about next steps.

Are clinical trials in Colorado Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Colorado Springs studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 6 active trials in Colorado Springs are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 18, 2026 from ClinicalTrials.gov